Alumis Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Alumis Inc
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
/ 
Frequently asked questions
To buy Alumis Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Alumis Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Alumis Inc is ALMS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Alumis Inc has its primary listing on NASDAQ. You can trade Alumis Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Alumis Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Alumis Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Alumis Inc.